Is Karyopharm Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 07:45 PM IST
share
Share Via
As of August 13, 2025, Karyopharm Therapeutics has a mildly bearish technical outlook, with mixed signals from indicators and significant underperformance compared to the S&P 500, showing a year-to-date return of -43.52%.
As of 13 August 2025, the technical trend for Karyopharm Therapeutics, Inc. has changed from bearish to mildly bearish. Currently, the weekly MACD and Bollinger Bands indicate a mildly bullish stance, while the daily moving averages and the weekly KST suggest a mildly bearish outlook. The RSI shows no signal in both weekly and monthly time frames, and Dow Theory reflects a mildly bearish trend on the weekly chart with no trend on the monthly.

In terms of performance, Karyopharm has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -43.52% compared to the S&P 500's 12.22%, and a one-year return of -48.13% versus 17.14% for the benchmark. Overall, the current technical stance is mildly bearish, indicating some weakness despite a few bullish signals.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Karyopharm Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:20 PM IST
share
Share Via
Is Karyopharm Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:58 AM IST
share
Share Via
What does Karyopharm Therapeutics, Inc. do?
Jun 22 2025 06:43 PM IST
share
Share Via
How big is Karyopharm Therapeutics, Inc.?
Jun 22 2025 06:01 PM IST
share
Share Via